← All organizations
Highest phase reached
Phase 3
Acquired by Ligand Pharmaceuticals on Aug 11, 2020
Timeline
2000s
- Dec 7, 2009
Pfenex, Inc— Founded
2010s
- Oct 4, 2019
teriparatide— Marketing Organization
2020s
- Aug 11, 2020
Ligand Pharmaceuticals— Acquired By
Drugs by trial phase (5 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (10)
- NCT03002428Lead sponsorPhase 3Dec 1, 2016
- NCT03002428Study directorPhase 3Dec 1, 2016
- NCT02656810Study directorPhase 1Dec 1, 2015
- NCT02656810Lead sponsorPhase 1Dec 1, 2015
- NCT02655549Study directorPhase 1Dec 1, 2015
- NCT02655549Lead sponsorPhase 1Dec 1, 2015
- NCT02474134Lead sponsorPhase 1Mar 1, 2015
- NCT02474134Study directorPhase 1Mar 1, 2015
- NCT02121353Lead sponsorPhase 1/Phase 2Nov 1, 2013
- NCT02121353Study directorPhase 1/Phase 2Nov 1, 2013
Details
- Founded
- San Diego, CA, US Dec 7, 2009
- Last known activity
- Dec 1, 2016
